<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30136" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thyroid Adenoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mulita</surname>
            <given-names>Francesk</given-names>
          </name>
          <aff>General University Hospital of Patras</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Francesk Mulita declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30136.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Thyroid adenomas are benign lesions of the thyroid gland. These lesions may be inactive or active in producing thyroid hormones. In the case of being active, they may be referred to as toxic thyroid adenomas. There are two types of thyroid adenomas, follicular and papillary. Most thyroid adenomas do not cause any symptoms and are usually diagnosed incidentally by ultrasound of the thyroid gland. Thyroid adenoma usually presents as a solitary thyroid nodule. It is important to exclude malignancies from the differential diagnosis because thyroid carcinoma mimics adenoma. This activity reviews the evaluation and treatment of thyroid adenoma and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of thyroid adenoma.</p></list-item><list-item><p>Review the appropriate evaluation of thyroid adenoma.</p></list-item><list-item><p>Outline the management options available for thyroid adenoma.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to improve the outcomes of patients with a thyroid adenoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30136&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30136">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30136.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The thyroid gland, consisting of two connected lobes, is one of the largest endocrine glands in the human body, weighing 20&#x000a0;to 30 g in adults.<xref ref-type="bibr" rid="article-30136.r1">[1]</xref> Thyroid lesions&#x000a0;are often found in the gland, with a prevalence&#x000a0;of 4%&#x000a0;to 7%. Most of them are asymptomatic, and thyroid hormone secretion remains normal. The majority of thyroid lesions are non-cancerous.&#x000a0;Benign lesions include simple&#x000a0;or hemorrhagic cysts, colloid nodules, and thyroid adenomas.<xref ref-type="bibr" rid="article-30136.r2">[2]</xref><xref ref-type="bibr" rid="article-30136.r3">[3]</xref><xref ref-type="bibr" rid="article-30136.r4">[4]</xref>&#x000a0;</p>
        <p>Thyroid adenomas are benign lesions of the thyroid gland. These lesions may be inactive or active in producing thyroid hormones. In the case of being active, they may be referred to as toxic thyroid adenomas. Patients with thyroid adenomas are usually asymptomatic. However, biochemical and clinical hyperthyroidism can be caused by a toxic adenoma, defined as an autonomously functioning thyroid nodule (AFTN). Most thyroid adenomas&#x000a0;do not cause any symptoms and are usually diagnosed incidentally by ultrasound of the thyroid gland. Less frequently, they might present as a palpable thyroid nodule or generally as an easily seen growth on a patient's neck.<xref ref-type="bibr" rid="article-30136.r5">[5]</xref></p>
      </sec>
      <sec id="article-30136.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most thyroid adenomas are sporadic and not hereditary. However, some environmental and genetic factors are associated with the presence of a thyroid adenoma. For example, iodine deficiency is a well-known environmental risk factor accused of causing the development of a thyroid adenoma, and it is the most common reason for the development of thyroid nodules around the world, especially in underdeveloped countries.&#x000a0;</p>
        <p>In addition, rare genetic mutations in BRAF, RET, KRAS, and genetic rearrangement of the PAX8-PPAR gene are strongly associated with the development of thyroid adenomas.<xref ref-type="bibr" rid="article-30136.r6">[6]</xref><xref ref-type="bibr" rid="article-30136.r7">[7]</xref>&#x000a0;Newer techniques have become available and more widespread in studying the molecular basis of thyroid adenomas, and they have helped differentiate benign versus malignant tumors.<xref ref-type="bibr" rid="article-30136.r8">[8]</xref><xref ref-type="bibr" rid="article-30136.r9">[9]</xref><xref ref-type="bibr" rid="article-30136.r6">[6]</xref></p>
      </sec>
      <sec id="article-30136.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Thyroid adenomas usually present as solitary thyroid nodules and are more common in female patients. In two autopsy series, the incidence of thyroid adenomas was 3% and 4.3%, respectively. The incidence of thyroid adenomas used to be higher in the past, especially in iodine-deficient areas (endemic goiter). However, in recent years, their incidence has been reported at much lower levels due to the use of iodine-enriched salt.<xref ref-type="bibr" rid="article-30136.r10">[10]</xref><xref ref-type="bibr" rid="article-30136.r11">[11]</xref></p>
      </sec>
      <sec id="article-30136.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Genetic rearrangement of the PAX8-PPAR gene is strongly associated with developing a thyroid adenoma. PAX8 is a gene involved in follicular cell differentiation. The PAX8-PPAR gene rearrangement has been found in 4%-13% of follicular adenoma cases.<xref ref-type="bibr" rid="article-30136.r6">[6]</xref> There are two major types of thyroid adenomas, functional and non-functional ones. Functional adenomas are more commonly the result of a monoclonal expansion of thyroid cells due to activating mutations in the TSH-receptor gene and less commonly due to a mutation in the adenylate cyclase stimulating G alpha protein gene. The K-RAS mutation is most commonly found in non-functional adenomas and is associated with developing thyroid carcinomas.<xref ref-type="bibr" rid="article-30136.r12">[12]</xref><xref ref-type="bibr" rid="article-30136.r13">[13]</xref></p>
      </sec>
      <sec id="article-30136.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Thyroid adenomas are homogeneous, solitary, and encapsulated tumors. They are usually classified as follicular or papillary based on pathology findings. The follicular type is the most commonly seen type, whereas the papillary adenomas are extremely rare. There are five subtypes of follicular adenomas:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fetal type</p>
          </list-item>
          <list-item>
            <p>Colloid type</p>
          </list-item>
          <list-item>
            <p>Embryonal type</p>
          </list-item>
          <list-item>
            <p>Hurthle cell type</p>
          </list-item>
          <list-item>
            <p>Hyalinizing trabecular type<xref ref-type="bibr" rid="article-30136.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>The classification of follicular adenomas into subtypes is based on histological findings such as cellular architecture and the amount of colloid content. It is highly recommended that thyroid adenomas be differentiated from thyroid carcinomas. This is usually done through histological evidence of capsular invasion and angioinvasion that strongly suggests when a thyroid lesion is of malignant nature.<xref ref-type="bibr" rid="article-30136.r15">[15]</xref><xref ref-type="bibr" rid="article-30136.r16">[16]</xref></p>
      </sec>
      <sec id="article-30136.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most patients won't know they have a thyroid adenoma until they undergo a complete and thorough physical examination. In some cases, they might present with a complaint of visible and palpable neck growth. The patients rarely complain of dyspnea due to tracheal compression, hoarseness due to laryngeal nerve irritation or dysphagia due to esophagus compression. Most of the time, the patients are clinically euthyroid without any symptoms suggesting hyperactive or hypoactive thyroid function. However, about 1% of the patients with thyroid adenomas can be hyperthyroid, and in that case, they might have a constellation of symptoms including, but not limited to, weight loss, increased anxiety, heart palpitations, excessive sweating, changes in the bowel habits as well as changes in the hair or the skin and menstrual irregularities in women of reproductive age.<xref ref-type="bibr" rid="article-30136.r15">[15]</xref></p>
      </sec>
      <sec id="article-30136.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic evaluation of a patient with a palpable thyroid nodule first includes a thyroid-stimulating hormone (TSH) level measurement to assess the functional baseline status of the thyroid gland, and afterward, an ultrasound examination of the thyroid gland, and ultimately a fine needle aspiration biopsy. All patients with a palpable thyroid nodule should have their thyroid hormone levels (TSH and thyroxine) checked. A toxic adenoma is suspected in patients with low TSH levels. These patients should undergo an iodine-123 thyroid scan in order to differentiate a hyperfunctioning nodule (toxic adenoma) from a hypofunctioning nodule.<xref ref-type="bibr" rid="article-30136.r17">[17]</xref></p>
        <p>A hyperfunctioning nodule is considered a benign lesion, as there is less than a 1% probability of malignancy. On the other hand, hypofunctioning nodules have a 20% probability of malignancy (through malignant transformation). However, most patients with a thyroid nodule are euthyroid, which means that TSH levels are within normal limits.&#x000a0;All patients should undergo an ultrasound (US) examination of the thyroid gland to differentiate a thyroid adenoma, which is considered a benign lesion, from thyroid carcinoma. Sonographic features associated with a higher risk of malignancy are hypoechogenicity, microcalcifications, irregular margins, absent halo sign, and increased intramodular blood flow.<xref ref-type="bibr" rid="article-30136.r18">[18]</xref><xref ref-type="bibr" rid="article-30136.r19">[19]</xref><xref ref-type="bibr" rid="article-30136.r20">[20]</xref>&#x000a0;The American Thyroid Association (ATA) has published guidelines for the differentiation and management of thyroid nodules and thyroid cancers, and they propose a scoring system using the ultrasound characteristics of the thyroid nodules.<xref ref-type="bibr" rid="article-30136.r21">[21]</xref> One of the newest radiology systems, called TIRADS, also uses a score sum based on points for the different features of the adenomas seen in the thyroid ultrasound. This score has been correlated with the risk of thyroid malignancy.<xref ref-type="bibr" rid="article-30136.r22">[22]</xref><xref ref-type="bibr" rid="article-30136.r23">[23]</xref><xref ref-type="bibr" rid="article-30136.r24">[24]</xref><xref ref-type="bibr" rid="article-30136.r25">[25]</xref></p>
        <p>Fine needle aspiration (FNA) has ultimately been used in evaluating a thyroid nodule with suspicious radiology features, especially in patients with a high risk of malignancy. It should be mentioned that fine-needle aspiration may not provide a definite diagnosis in all cases. In patients with thyroid adenoma, the cytological sample has organized follicular epithelial cells. On the other hand, aspiration can show follicular cells with abnormal architecture and atypia. These patients are characterized as having atypia of undetermined significance.<xref ref-type="bibr" rid="article-30136.r26">[26]</xref>&#x000a0;A benign thyroid adenoma is confirmed only after ruling out capsular and vessel invasion in the final histological examination done by pathologists after a partial or total thyroidectomy operation. Genetic testing has also helped a lot in predicting the risk of thyroid cancer, and it has frequently been used in the final decision-making of proceeding to surgical intervention of removing a thyroid nodule versus not.<xref ref-type="bibr" rid="article-30136.r27">[27]</xref></p>
      </sec>
      <sec id="article-30136.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In some asymptomatic patients with small thyroid adenomas and no malignancy found by fine needle aspiration, regular monitoring with repeat ultrasonography is usually recommended.&#x000a0;The FNA might need to be repeated if the nodule grows in size in future examinations or if other suspicious features are seen in a radiologic evaluation with an ultrasound.<xref ref-type="bibr" rid="article-30136.r2">[2]</xref>&#x000a0;The development of accurate molecular genetic testing of thyroid tissue&#x000a0;obtained during thyroid biopsies has helped decrease unnecessary surgeries or at least limit the number of total thyroidectomies and favor less extensive thyroid gland operations.<xref ref-type="bibr" rid="article-30136.r28">[28]</xref><xref ref-type="bibr" rid="article-30136.r29">[29]</xref><xref ref-type="bibr" rid="article-30136.r30">[30]</xref><xref ref-type="bibr" rid="article-30136.r31">[31]</xref></p>
        <p>For patients with benign thyroid adenomas, thyroid lobectomy and isthmusectomy is a sufficient surgical treatment. This procedure is also adequate for patients with minimally invasive thyroid cancer. When histological examination shows no signs of malignancy, then no further intervention is required. These patients should only continue to have their thyroid hormone status regularly checked.<xref ref-type="bibr" rid="article-30136.r15">[15]</xref><xref ref-type="bibr" rid="article-30136.r32">[32]</xref></p>
        <p>Non-euthyroid patients&#x000a0;with a solitary toxic nodule, which is a functioning thyroid adenoma, may be treated with anti-thyroid drugs to achieve a euthyroid state. Treatments with iodine-131 therapy or thyroidectomy are also recommended options. The advantages of surgical therapy are relief from compressive symptoms, immediate resolution of hyperthyroidism, and avoidance of radiation exposure to the normal part of the thyroid gland.<xref ref-type="bibr" rid="article-30136.r15">[15]</xref><xref ref-type="bibr" rid="article-30136.r33">[33]</xref>&#x000a0;The use of local ethanol injections for ablation purposes of a toxic adenoma has been used in specialized centers, but it is not widely popular with questionable long-term effectiveness.<xref ref-type="bibr" rid="article-30136.r34">[34]</xref></p>
      </sec>
      <sec id="article-30136.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Thyroid adenoma typically presents as a solitary nodule and should therefore be differentiated from:</p>
        <list list-type="bullet">
          <list-item>
            <p>A cyst (parathyroid or thyroglossal)</p>
          </list-item>
          <list-item>
            <p>Multinodular goiter</p>
          </list-item>
          <list-item>
            <p>Parathyroid adenoma</p>
          </list-item>
          <list-item>
            <p>Thyroiditis</p>
          </list-item>
          <list-item>
            <p>Carcinoma (follicular, papillary, medullary, parathyroid, or any other carcinoma)<xref ref-type="bibr" rid="article-30136.r4">[4]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30136.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Thyroid adenomas are the most common benign lesions and have an excellent prognosis.</p>
        <p>However, there is a 20% probability of malignant transformation. In these cases, oncological management and&#x000a0;an interprofessional team approach are necessary.<xref ref-type="bibr" rid="article-30136.r35">[35]</xref><xref ref-type="bibr" rid="article-30136.r36">[36]</xref></p>
      </sec>
      <sec id="article-30136.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Most patients with thyroid adenomas are asymptomatic. However, patients with functioning thyroid adenoma may have symptoms of hyperthyroidism, such as fatigue, sweating, tremor, palpitations, and anxiety.<xref ref-type="bibr" rid="article-30136.r37">[37]</xref> Some patients may complain of dyspnea, hoarseness of voice, and dysphagia due to compression of the trachea or esophagus by a growing thyroid tumor.<xref ref-type="bibr" rid="article-30136.r15">[15]</xref></p>
      </sec>
      <sec id="article-30136.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The following consultations are required in cases of thyroid adenomas:</p>
        <list list-type="bullet">
          <list-item>
            <p>Endocrinology</p>
          </list-item>
          <list-item>
            <p>Radiology</p>
          </list-item>
          <list-item>
            <p>Surgery (general or specialized endocrine)</p>
          </list-item>
          <list-item>
            <p>Pathology</p>
          </list-item>
          <list-item>
            <p>Nuclear medicine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30136.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As a result of the widespread use of ultrasound for evaluating different pathologies of the neck, many people have been found to have incidental thyroid nodules. Patients should be reassured that the majority of these nodules are benign lesions and they are too small to be palpated. Ultrasound-guided FNA should be done for the larger lesions, which can most of the time be palpated.<xref ref-type="bibr" rid="article-30136.r38">[38]</xref><xref ref-type="bibr" rid="article-30136.r10">[10]</xref></p>
      </sec>
      <sec id="article-30136.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>A close collaboration between an endocrinologist, a radiologist, and an experienced endocrine neck surgeon is warranted for the best approach to thyroid adenomas. The benign tumors do not need any aggressive management and can be followed conservatively, but the thyroid nodules showing suspicious radiographic features should be looked at more closely. A thyroid biopsy by fine needle aspiration is considered routine testing, and depending on its cytology results, the final treatment decision can be made. Different scoring systems have been developed to help differentiate benign versus malignant nodules, and further molecular genetic testing can assist medical providers in avoiding unnecessary interventions or more testing. The medical team should spend time explaining the process and the different steps to the patients in detail to increase the comfort level and patient collaboration.</p>
      </sec>
      <sec id="article-30136.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Although&#x000a0;thyroid adenomas are usually benign lesions, they should be monitored continuously for malignant potential; this requires the involvement of an interprofessional healthcare team consisting of clinicians (MDs, DOs, NPs, and PAs), specialists (particularly an endocrinologist), nursing staff, and depending on the therapeutic path chosen, possibly pharmacists. Clinicians may note the lesions on routine testing, and any ambiguity about how to proceed or the differential&#x000a0;should involve an endocrinology consult. Nurses can assist in evaluation, counsel the patient, help monitor the condition, and coordinate activities between the various clinical personnel involved. In cases where thyroid tissue is surgically or otherwise removed or ablated, thyroid hormone therapy may be necessary, necessitating&#x000a0;pharmacists performing medication reconciliation, verifying dosing, and patient&#x000a0;medication counseling. The interprofessional team approach will help drive optimal patient outcomes with the fewest adverse events. [Level 5]</p>
        <p>The probability of malignancy for palpable thyroid lesions is higher than for non-palpable nodules.<xref ref-type="bibr" rid="article-30136.r39">[39]</xref> To date, there is no evidence supporting ultrasound screening for non-palpable thyroid nodules.<xref ref-type="bibr" rid="article-30136.r40">[40]</xref>&#x000a0;Thyroid adenomas remain a challenge for healthcare workers regarding their diagnosis and management. Collaboration and teamwork&#x000a0;between different specialists can enhance the outcomes of these cases.</p>
      </sec>
      <sec id="article-30136.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30136&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30136">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/thyroid-adenoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30136">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30136/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30136">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30136.s18">
        <title>References</title>
        <ref id="article-30136.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beynon</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pinneri</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>An Overview of the Thyroid Gland and Thyroid-Related Deaths for the Forensic Pathologist.</article-title>
            <source>Acad Forensic Pathol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-236</page-range>
            <pub-id pub-id-type="pmid">31239894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welker</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Orlov</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Thyroid nodules.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Feb</month>
            <day>01</day>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>559</fpage>
            <page-range>559-66</page-range>
            <pub-id pub-id-type="pmid">12588078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dean</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gharib</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of thyroid nodules.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>901</fpage>
            <page-range>901-11</page-range>
            <pub-id pub-id-type="pmid">19041821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tamhane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gharib</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Thyroid nodule update on diagnosis and management.</article-title>
            <source>Clin Diabetes Endocrinol</source>
            <year>2016</year>
            <volume>2</volume>
            <fpage>17</fpage>
            <pub-id pub-id-type="pmid">28702251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>LaPorte</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ultrasonography of thyroid nodules: a pictorial review.</article-title>
            <source>Insights Imaging</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-86</page-range>
            <pub-id pub-id-type="pmid">26611469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Iuliano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Le Pera</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sama'</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Monaco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cammarota</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiariotti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>87</volume>
            <issue>10</issue>
            <fpage>4728</fpage>
            <page-range>4728-35</page-range>
            <pub-id pub-id-type="pmid">12364466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue.</article-title>
            <source>Oncol Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>3359</fpage>
            <page-range>3359-3369</page-range>
            <pub-id pub-id-type="pmid">30272326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hossain</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Asa</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Uddin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moustafa</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>JMW</given-names>
              </name>
              <name>
                <surname>Moni</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2020</year>
            <month>Feb</month>
            <day>20</day>
            <volume>17</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">32093341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Vence</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chantada-V&#x000e1;zquez</surname>
                <given-names>MDP</given-names>
              </name>
              <name>
                <surname>Cameselle-Teijeiro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bravo</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A Novel Nanoproteomic Approach for the Identification of Molecular Targets Associated with Thyroid Tumors.</article-title>
            <source>Nanomaterials (Basel)</source>
            <year>2020</year>
            <month>Nov</month>
            <day>28</day>
            <volume>10</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">33260544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bisi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>de Camargo</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Abdo</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>de Brito</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma.</article-title>
            <source>Cancer</source>
            <year>1989</year>
            <month>Nov</month>
            <day>01</day>
            <volume>64</volume>
            <issue>9</issue>
            <fpage>1888</fpage>
            <page-range>1888-93</page-range>
            <pub-id pub-id-type="pmid">2676140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rochau</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Qerimi Rushaj</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;nhensch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stojkov</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jahn</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hubalewska-Dydejczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erlund</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Thuesen</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moreno-Reyes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lzke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Siebert</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview.</article-title>
            <source>Thyroid</source>
            <year>2020</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>746</fpage>
            <page-range>746-758</page-range>
            <pub-id pub-id-type="pmid">31964247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Challeton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bounacer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Du Villard</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Caillou</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>De Vathaire</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Monier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schlumberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.</article-title>
            <source>Oncogene</source>
            <year>1995</year>
            <month>Aug</month>
            <day>03</day>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>601</fpage>
            <page-range>601-3</page-range>
            <pub-id pub-id-type="pmid">7630645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Kwak</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Analysis of <italic>RAS</italic> mutation in thyroid nodular hyperplasia and follicular neoplasm in a Korean population.</article-title>
            <source>Endocrinol Diabetes Metab</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>e00040</fpage>
            <pub-id pub-id-type="pmid">30815568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saglietti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Piana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>La Rosa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bongiovanni</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hyalinizing trabecular tumour of the thyroid: fine-needle aspiration cytological diagnosis and correlation with histology.</article-title>
            <source>J Clin Pathol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>70</volume>
            <issue>8</issue>
            <fpage>641</fpage>
            <page-range>641-647</page-range>
            <pub-id pub-id-type="pmid">28424236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McHenry</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Phitayakorn</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Follicular adenoma and carcinoma of the thyroid gland.</article-title>
            <source>Oncologist</source>
            <year>2011</year>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>585</fpage>
            <page-range>585-93</page-range>
            <pub-id pub-id-type="pmid">21482585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baloch</surname>
                <given-names>ZW</given-names>
              </name>
              <name>
                <surname>Asa</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Barletta</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ghossein</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Juhlin</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>LiVolsi</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Papotti</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sobrinho-Sim&#x000f5;es</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tallini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mete</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Overview of the 2022 WHO Classification of Thyroid Neoplasms.</article-title>
            <source>Endocr Pathol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-63</page-range>
            <pub-id pub-id-type="pmid">35288841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tonacchera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grosso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orsolini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vitti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>304</fpage>
            <page-range>304-312</page-range>
            <pub-id pub-id-type="pmid">33008929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Avanzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Treseler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ituarte</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Streja</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Siperstein</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Duh</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>OH</given-names>
              </name>
            </person-group>
            <article-title>Follicular thyroid carcinoma: histology and prognosis.</article-title>
            <source>Cancer</source>
            <year>2004</year>
            <month>Mar</month>
            <day>15</day>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>1123</fpage>
            <page-range>1123-9</page-range>
            <pub-id pub-id-type="pmid">15022277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sampietro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rosai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pilotti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma.</article-title>
            <source>Virchows Arch</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>442</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-6</page-range>
            <pub-id pub-id-type="pmid">12536317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borowczyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woli&#x00144;ski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wi&#x00119;ckowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jod&#x00142;owska-Siewert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Szczepanek-Parulska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Verburg</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Rucha&#x00142;a</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma-A Meta-Analysis.</article-title>
            <source>Cancers (Basel)</source>
            <year>2021</year>
            <month>Feb</month>
            <day>24</day>
            <volume>13</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33668130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haugen</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Bible</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Mandel</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nikiforov</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Pacini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Randolph</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Sawka</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Schlumberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schuff</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Steward</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tuttle</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-133</page-range>
            <pub-id pub-id-type="pmid">26462967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ghaznavi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Symonds</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kinnear</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paschke</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Improvement in thyroid ultrasound report quality with radiologists' adherence to 2015 ATA or 2017 TIRADS: a population study.</article-title>
            <source>Eur Thyroid J</source>
            <year>2022</year>
            <month>Jun</month>
            <day>14</day>
            <volume>11</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">35521979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lamartina</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ascoli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bosco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Biffoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giacomelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maranghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramundo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cantisani</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Filetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Durante</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>104</volume>
            <issue>1</issue>
            <fpage>95</fpage>
            <page-range>95-102</page-range>
            <pub-id pub-id-type="pmid">30299457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castellana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Radzina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Giovanella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Deandrea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ngu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Durante</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trimboli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules: a meta-analysis.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>183</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-264</page-range>
            <pub-id pub-id-type="pmid">32544875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koc</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ad&#x00131;belli</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Erkul</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dilek</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Comparison of diagnostic accuracy of ACR-TIRADS, American Thyroid Association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy.</article-title>
            <source>Eur J Radiol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>133</volume>
            <fpage>109390</fpage>
            <pub-id pub-id-type="pmid">33181485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>SZ</given-names>
              </name>
            </person-group>
            <article-title>Terminology and nomenclature schemes for reporting thyroid cytopathology: An overview.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>258</fpage>
            <page-range>258-63</page-range>
            <pub-id pub-id-type="pmid">25680862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vargas-Salas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Urra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dom&#x000ed;nguez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mena</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Uslar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lagos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Henr&#x000ed;quez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Genetic testing for indeterminate thyroid cytology: review and meta-analysis.</article-title>
            <source>Endocr Relat Cancer</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>R163</fpage>
            <page-range>R163-R177</page-range>
            <pub-id pub-id-type="pmid">29255094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jug</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Datto</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>XS</given-names>
              </name>
            </person-group>
            <article-title>Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>126</volume>
            <issue>7</issue>
            <fpage>471</fpage>
            <page-range>471-480</page-range>
            <pub-id pub-id-type="pmid">29637728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Pantanowitz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Faquin</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>The Role of Molecular Testing for the Indeterminate Thyroid FNA.</article-title>
            <source>Genes (Basel)</source>
            <year>2019</year>
            <month>Sep</month>
            <day>23</day>
            <volume>10</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">31547603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livhits</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Douek</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Beckett</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Zanocco</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gofnung</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Smooke-Praw</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>2261</fpage>
            <page-range>2261-2268</page-range>
            <pub-id pub-id-type="pmid">29590358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steward</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Carty</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sippel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sipos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Figge</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mandel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haugen</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Baloch</surname>
                <given-names>ZW</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Seethala</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Gooding</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Chiosea</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Gomes-Lima</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferris</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Folek</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kundra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Mayson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Nga</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ngiam</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Nikiforova</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Poehls</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ringel</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nikiforov</surname>
                <given-names>YE</given-names>
              </name>
            </person-group>
            <article-title>Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.</article-title>
            <source>JAMA Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-212</page-range>
            <pub-id pub-id-type="pmid">30419129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma.</article-title>
            <source>Cancer Manag Res</source>
            <year>2021</year>
            <volume>13</volume>
            <fpage>3991</fpage>
            <page-range>3991-4002</page-range>
            <pub-id pub-id-type="pmid">34040440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miccoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Minuto</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Galleri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Basolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Antonangeli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aghini-Lombardi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease.</article-title>
            <source>ANZ J Surg</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>76</volume>
            <issue>3</issue>
            <fpage>123</fpage>
            <page-range>123-6</page-range>
            <pub-id pub-id-type="pmid">16626346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>VASCULARITY-TARGETED PERCUTANEOUS ETHANOL INJECTION OF TOXIC THYROID ADENOMAS: OUTCOMES OF A FEASIBILITY STUDY PERFORMED IN THE USA.</article-title>
            <source>Endocr Pract</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-29</page-range>
            <pub-id pub-id-type="pmid">31461356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marques</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Espadinha</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Catarino</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Moniz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sobrinho</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Leite</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>8</issue>
            <fpage>3947</fpage>
            <page-range>3947-52</page-range>
            <pub-id pub-id-type="pmid">12161538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitahara</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>K Rmendin&#x000e9; Farkas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>J&#x000f8;rgensen</surname>
                <given-names>JOL</given-names>
              </name>
              <name>
                <surname>Cronin-Fenton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>2216</fpage>
            <page-range>2216-2224</page-range>
            <pub-id pub-id-type="pmid">29590402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Leo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Hyperthyroidism.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Aug</month>
            <day>27</day>
            <volume>388</volume>
            <issue>10047</issue>
            <fpage>906</fpage>
            <page-range>906-918</page-range>
            <pub-id pub-id-type="pmid">27038492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pacini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Groot</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <chapter-title>Thyroid Nodules</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2016</year>
            <month>7</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">25905399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Gharib</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging.</article-title>
            <source>Ann Intern Med</source>
            <year>1997</year>
            <month>Feb</month>
            <day>01</day>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>226</fpage>
            <page-range>226-31</page-range>
            <pub-id pub-id-type="pmid">9027275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30136.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Sarne</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Long-term risks for thyroid cancer and other neoplasms after exposure to radiation.</article-title>
            <source>Nat Clin Pract Endocrinol Metab</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>82</fpage>
            <page-range>82-91</page-range>
            <pub-id pub-id-type="pmid">16929376</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
